Francisco Portillo Selected Research

Francisco Portillo Research Topics

8	Neoplasms (Cancer) 01/2021 - 10/2005
5	Neoplasm Metastasis (Metastasis) 04/2022 - 12/2007
4	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2007
4	Carcinoma (Carcinomatosis) 01/2010 - 01/2004
3	Carcinogenesis 06/2020 - 01/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015 - 06/2008
2	Melanoma (Melanoma, Malignant) 02/2022 - 01/2018
2	Starvation 08/2015 - 01/2005
1	Adenocarcinoma 04/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Hyperalgesia 09/2019
1	Osteoarthritis 09/2019
1	Genomic Instability 01/2018
1	Pathologic Processes 04/2015
1	Fibrosis (Cirrhosis) 04/2015
1	Leukemia 08/2014
1	Myotonia Congenita (Thomsen Disease) 03/2012
1	Muscular Diseases (Myopathy) 03/2012

9	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 04/2022 - 10/2005
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2010
4	Cadherins (E-Cadherin)IBA 01/2010 - 01/2004
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2006
1	CollagenIBA 04/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2021
1	HomocysteineIBA 06/2020
1	Methionine (L-Methionine)FDA Link 06/2020
1	Iodoacetic AcidIBA 09/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018
1	Multifunctional EnzymesIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 08/2015
1	AntibodiesIBA 08/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 05/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2015
1	Differentiation AntigensIBA 04/2015
1	ChromatinIBA 08/2014
1	Chloride Channels (Chloride Channel)IBA 03/2012
1	Messenger RNA (mRNA)IBA 09/2011
1	Indicators and Reagents (Reagents)IBA 06/2008
1	Docetaxel (Taxotere)FDA Link 12/2007
1	Gemcitabine FDA Link 12/2007
1	EnzymesIBA 10/2005
1	Biological ProductsIBA 10/2005
1	CarbonIBA 01/2005